LEO Innovation Lab

LEO Innovation Lab operates as an autonomous entity established by LEO Pharma to address unmet patient needs through digital innovation. Founded as part of a strategic initiative to transform healthcare delivery, the lab focuses specifically on developing solutions that enhance quality of life for individuals managing chronic dermatological conditions. This specialized incubator represents LEO Pharma's commitment to expanding beyond traditional pharmaceutical approaches by embracing technological advancements in healthcare.

With its headquarters in Copenhagen and satellite operations across multiple continents, LEO Innovation Lab leverages a global perspective to identify and nurture promising healthcare technologies. The organization's international presence enables it to tap into diverse innovation ecosystems, connecting with entrepreneurs and researchers worldwide who share their mission of revolutionizing dermatological care. This expansive network allows the lab to identify emerging trends and technologies with potential applications for skin health management across different markets and healthcare systems.

The investment approach at LEO Innovation Lab centers on disruptive digital health solutions with particular emphasis on dermatology applications. Their portfolio typically includes early-stage companies developing patient-centric technologies such as diagnostic tools, treatment adherence platforms, remote monitoring systems, and AI-powered clinical decision support. By providing both capital and strategic guidance, the lab helps portfolio companies navigate the complex healthcare landscape while maintaining focus on measurable patient outcomes and clinical validation.

Beyond traditional venture investment, LEO Innovation Lab distinguishes itself through its company building capabilities, actively creating and scaling new ventures from concept to market. This hands-on approach involves assembling dedicated teams, providing technical infrastructure, and offering regulatory expertise specific to healthcare innovation. The lab's dual focus on external investments and internal venture creation positions it uniquely within the digital health ecosystem as both an investor and innovation partner committed to transforming dermatological care through technological advancement and patient-centered design principles.